Session: What Have We Learned: A Conversation on 15 Years of Spinosad Use in Public Health Symposium
116 - Deploying spinosad for pre-treatment larval control management strategies in the Cayman Islands
Tuesday, March 5, 2024
4:25pm – 4:35pm
Location: D3
Abstract: Pretreatment applications of larvicides are an important tool in the prevention of large hatch-offs of mosquito broods. Understanding the treatment window and reliability of formulations for pre-treatment applications is critical to operational success. In a collaborative trial, the Cayman Islands Mosquito Research Control Unit and Clarke explored the pre-treatment viability of Natular® G30, a spinosad-based granular larvicide. A mix of field, laboratory, and analytical tests were used to assess the active ingredient’s rate of degradation and validate its residual efficacy potential. Study results have informed Cayman Island’s continued operational use of Natular G30 as an effective pre-treatment tool for larval control.
